Illumina Names New Executives, Denator Brings Aboard Sales Execs, King and Cassigneul Join PMC Board, and More | GenomeWeb
This article has been updated from a previous version to correct Stephen Pentoney's title. He has been appointed vice president of assay and reagent development at Illumina, not as VP of array biochemistry as the company had previously reported.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.